Earnings Call Excerpt
MedImmune, Inc., (MEDI)
Q2 2006 Earnings Conference Call
July 20, 2006, 8:00 a.m. EST
Executives:
David M. Mott, Vice Chairman, CEO, and President
Lota Zoth, Senior Vice President and CFO
James F. Young, President, Research and Development
Edward M. Connor, M.D., Executive Vice President and Chief Medical Officer
Peter Greenleaf, Senior Vice President, Marketing and Sales
Peter Vozzo, Investor Relations
Analysts:
Steven Harr, Morgan Stanley
Jason Zhang, Prudential
Joel Sendek, Lazard & Co.
Geoffrey Porges, Sanford C. Bernstein & Co.
Mark Schoenebaum, Bear, Stearns & Co.
May-kin Ho, Ph.D., Goldman Sachs & Co.
Chris Demetropoulous, JP Morgan
Craig Parker, Lehman Brothers
Brian Lian, CIBC World Markets
Presentation
Operator
Good day ladies and gentlemen and welcome to the Second Quarter 2006 MedImmune Earnings Conference Call. My name is Luanda and I will be your coordinator for today. At this time all participants are in a listen-only mode. We will conduct a question and answer session towards the end of the conference. If at any time during the call should you require assistance, please key * followed by 0 and a coordinator will be happy to assist you. As a reminder, this conference is being recorded for replay purposes. I would now like to turn the call over to Mr. Peter Vozzo, Director of Investor Relations, please proceed.
Peter Vozzo, Investor Relations
Good morning and welcome to MedImmune’s quarterly conference call with investors. This call is being electronically recorded and is copyrighted by MedImmune. No reproductions, transmissions or copies of this conference call can be made without the written permission of MedImmune.
In this call, members of our senior management will discuss MedImmune’s financial results for the second quarter and first six months of 2006 as well as the company’s business outlook going forward. Please note that any statements about the company’s prospects or future expectations are forward-looking statements. As you know, forward-looking statements involve substantial risks and uncertainties and actual results may differ materially from expectations. Please refer to the press release issued earlier today that is related to this call and to our filings with the SEC for more information on the risks and uncertainties that could cause actual results to differ. Please note that as part of this morning’s press release and filing with the SEC, we have included schedules that present the most directly comparable GAAP measures for each historical non-GAAP measure as well as a detailed reconciliation between the two. Also, MedImmune assumes no obligation to update the information in this morning’s press release or as presented on this call, except as maybe required by applicable laws or regulations. Today’s press release describing our results for the second quarter and first six months of 2006 may be found on our website at www.medimmune.com and the box marked news are with the archived press releases on the investor relations page. And now, I will hand the call over to David Mott, MedImmune’s President and Chief Executive Officer.
- To read the full transcript on Seeking Alpha, click here »
